Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.
| Autor: | Kanbayashi, Yuko1 (AUTHOR) yuko.kambayashi@ompu.ac.jp, Tsuchiya, Eren2 (AUTHOR), Shimizu, Tadashi3 (AUTHOR), Uchida, Mayako2 (AUTHOR) |
|---|---|
| Zdroj: | DARU: Journal of Pharmaceutical Sciences. 4/26/2024, Vol. 32 Issue 1, p279-287. 9p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|